Bausch Health Company Executives
| BHC Stock | CAD 7.02 0.12 1.74% |
Bausch Health employs about 20.3 K people. The company is managed by 21 executives with a total tenure of roughly 16 years. For Bausch Health Companies, management analysis helps investors assess whether leadership decisions support the broader investment thesis or introduce new operating risk. The better read usually comes from comparing management claims with operating results, tenure stability, and capital-allocation outcomes over time.
| Thomas Appio President President & Co-Head Bausch + Lomb/International |
Bausch |
Management Team Effectiveness
The company has return on total asset (ROA) of 5.18 % meaning that for every 100 dollars of assets, it generated a profit of $5.18. This is consistent with industry norms. Similarly, it shows a return on equity (ROE) of 43.64 %, meaning that it earned $43.64 on each $100 of shareholder capital deployed.As of 03/24/2026, Net Income Applicable To Common Shares is forecasted to advance to approximately 164.8 M this year, while Common Stock Shares Outstanding is moving lower toward about 254.8 M.
Outstanding Bonds
Bausch Health Companies may use bonds as part of its capital structure to fund operations, refinance liabilities, or support acquisitions and other long-duration investments. Used together with earnings and cash-flow analysis, the bond stack can reveal whether leverage is a manageable tool or a developing constraint.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Shares in Circulation | First Issued 1994-03-31 | Previous Quarter 373.1 M | Current Value 370.5 M | Average Shares Outstanding 236.6 M | Quarterly Volatility 109.7 M |
Macro event markers
Holders Distribution
For Bausch Health Companies, institutional participation can be supportive or destabilizing depending on whether large holders are building conviction or reducing exposure. The better interpretation comes from watching concentration, turnover, and changes in holder behavior instead of assuming institutional ownership is automatically bullish.
Market Cap and Value
Workforce Comparison
Bausch Health Companies takes the leading position in number of employees compared to key competitors. The total workforce of Health Care industry is currently estimated at about 29,306. Bausch Health totals roughly 20,300 in number of employees claiming about 69% of equities under Health Care sector.
Profit Margins
The company has Profit Margin (PM) of 2.0 %, which indicates that even a small decline in its sales could erase profits. . Similarly, it shows Operating Margin (OM) of 26.0 %, which means that operating efficiency produces $26.0 per $100 of revenue.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.81 | 0.6833 |
|
|
Benchmark Summation
Operator |
This analysis covers sixty-one data points across the selected time horizon. Bausch Health Companies Price Series Summation is a cross summation of Bausch Health price series and its benchmark/peer.
Notable Stakeholders
Stakeholder analysis for Bausch Health is useful because companies often face trade-offs among groups that want very different outcomes from the same business. The stronger interpretation comes from connecting stakeholder presence with management behavior, governance patterns, and changes in the operating story.
| Thomas Appio | President & Co-Head Bausch + Lomb/International | Profile | |
| Mirza Dautbegovic | Executive COO | Profile | |
| John Barresi | Controller, VP | Profile | |
| Garen Sarafian | VP Relations | Profile | |
| Steven Lee | Controller VP | Profile | |
| MSc MD | Chief VP | Profile | |
| Jeff Hartness | Commercial Access | Profile | |
| Kathleen Fitzpatrick | Executive Officer | Profile | |
| Arthur Shannon | IR Contact Officer | Profile | |
| Jiny MBA | Senior Medical | Profile | |
| Tage MD | Chief RD | Profile | |
| William Woodfield | Senior Treasurer | Profile | |
| Donald Pearl | Senior Dermatologics | Profile | |
| Robert Butz | VP Affairs | Profile | |
| JeanJacques Charhon | Chief Officer | Profile | |
| Aimee Lenar | Executive Pharma | Profile | |
| Seana Carson | Executive Counsel | Profile | |
| Josh Coyle | Senior Salix | Profile | |
| Graham Jackson | Senior Officer | Profile | |
| Thomas Vadaketh | Ex CFO | Profile | |
| Cees Heiman | Senior Canada | Profile |
Management Information & Data Sources
Bausch Health is a mid-cap company in Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Executive review focuses on insiders, senior management, and employee signals. Leadership stability matters when evaluating execution against stated business priorities. Bausch Health employs 20,300 people.
For Bausch Health Companies, this section uses periodic company reporting and market reference feeds and standardizes the results for cross-period comparison. Intraday timing differences may exist. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Investors reviewing Bausch Health Companies can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. Used correctly, manpower metrics can highlight whether growth is being supported by better productivity or by heavier staffing costs.
Bausch Health Manpower Efficiency
Return on Bausch Health Manpower
| Revenue Per Employee | 514.6K | |
| Revenue Per Executive | 497.4M | |
| Net Income Per Employee | 7.9K | |
| Net Income Per Executive | 7.6M | |
| Working Capital Per Employee | 97.4K | |
| Working Capital Per Executive | 94.1M |
More Resources for Bausch Stock Analysis
A broader look at Bausch Health Companies comes from its financial reports and historical data. These indicators describe how financial results are generated.Bausch Health has a market cap of 2.56 B, operating margin of 25.79%, current ratio of 1.21. Use Trending Equities to view allocation positioning. Tracking Bausch Health Companies in a portfolio provides context for performance attribution. Position sizing depends on the allocation methodology selected for the portfolio. Broader economic conditions can influence Bausch Health Companies's company valuation — related indicators include signals in inflation. Bausch Health currently shows ROE of 43.64%, market cap of 2.56 Billion. Bausch Health data on this page supports broader research - the resources below add portfolio-level context. Within the Healthcare space, Bausch Health peer comparison and risk tools below help frame relative strengths and weaknesses. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.